Long-Acting ART Rollout: 3 Considerations for Clinicians
Four months after the approval of cabotegravir/rilpivirine, medical providers still face some tough questions about who might best benefit and how the medication might be covered.
This Week in HIV Research: It’s Not Just About HIV
June 3, 2021: Kaposi sarcoma despite ART; heat-based cervical HPV treatment; re-evaluating HIV-associated neurocognitive disorder; HIV and diabetes in Texas.
The Unequal Impact of Anti-LGBTQ Policies: Researchers Call for ‘All Hands on Deck’ to Protect Black Men
New research finds state-level inequities are associated with worse health outcomes for Black gay, bisexual, and queer men.
Rethinking Power—and Who Holds It—in HIV Organizations
Venita Ray's ascendancy to the co-directorship of Positive Women’s Network-USA is part of a broader effort within community-based organizations to thoughtfully center the voices of Black and Brown people.
Our Newest Posts
This Week in HIV Research: The Burdens We Bear
June 10, 2021: Trauma, burden, and COVID-19 risk among PLWH; sleep and viral suppression; spirituality/religioisity, depression, and HIV risk; why anal cancer screening isn't enough.
COVID-19 Vaccines and the LGBTQ Community: The Messenger Matters
Fearing discrimination and mistreatment, a significant number of LGBTQ folks are in no rush to get vaccinated, surveys show.
A Plan to End Hepatitis C in Michigan Through Harm Reduction and Compassionate Care
Ranked as 7th in the nation for HCV prevalence, Michigan launches an initiative to expand testing, treatment, and assistance and reduce stigma.
Activists in Georgia Are Working to Modernize HIV Criminalization Laws
Laws that criminalize not disclosing one’s HIV status increase stigma and discrimination—and ignore scientific evidence.
Trends in Liver Cancer Among HIV-Positive People in North America
A large study finds an increased risk for liver cancer in some HIV-positive people—and offers several interventions that could help reduce the risk.
This Week in HIV Research: Welcome to the Real World
May 27, 2021: Recycling tenofovir in a second-line regimen; real-life two-drug regimen failure rates; jump-starting ART at sexual health clinics; viability of wearable devices in sleep assessment.
Refer your clients and patients to TheBody, TheBodyPro's sibling site for people living with or affected by HIV. TheBody delivers vital information, news, support, and personal perspectives on HIV and related issues.
